Literature DB >> 28521481

Increased methylation of human papillomavirus type 16 DNA is associated with the severity of cervical lesions in infected females from northeast China.

Wei Wang1, Zhengrong Sun2, Jianhua Liu1,3, Guili Wang1, Zhitao Lu1, Weiqiang Zhou1, Te Qi1, Qiang Ruan1.   

Abstract

Hypermethylation of the cytosine-phosphate-guanine (CpG) sites located at the 3'-major capsid protein L1 (3'L1) and the long control region (LCR) of the human papillomavirus (HPV) genome may be associated with the progression of cervical cancer (CC). However, the methylation status of the LCR of HPV type 16 DNA remains to be elucidated in an infected Chinese population. The aim of the present study was to investigate the association between methylation of the HPV 16 L1 gene and LCR, and the severity of cervical lesions in infected female patients. Therefore, bisulfite modification, polymerase chain reaction amplification and sequencing were used to analyze 122 HPV 16-positive clinical cervical swabs obtained from patients in northeastern China. The proportion of methylated samples at each of the 7 CpG sites within the 3'-L1/5'-LCR and 5 CpG sites within the promoter region was significantly increased in patients with CC, compared with that observed in high-grade squamous intraepithelial lesions (HSIL) and normal tissue/low-grade intraepithelial lesions (LSIL) (χ2 test, P<0.01). The mean methylation frequencies of the CpG sites 7,089 and 7,143 exhibited an area under the curve value of 0.822 [95% confidence interval (CI)=0.733-0.911] for distinguishing CC from other lesions, 0.787 (95% CI=0.700-0.874) for distinguishing normal/LSIL from HSIL and CC, and 0.763 (95% CI=0.652-0.874) for distinguishing CC from HSIL. These results suggest that the methylation of CpG sites within the HPV 16 3'-L1 and LCR region is correlated with the severity of cervical lesions. Quantification of HPV DNA methylation in the L1 gene and promoter region appears to provide a promising novel marker for distinguishing between normal tissue/LSIL, HSIL and CC in a Chinese population.

Entities:  

Keywords:  3′-major capsid protein L1 gene; cervical lesion; human papillomavirus type 16; long control region; methylation

Year:  2017        PMID: 28521481      PMCID: PMC5431240          DOI: 10.3892/ol.2017.5903

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

Review 1.  Human papillomavirus and molecular considerations for cancer risk.

Authors:  Martin A Whiteside; Erin M Siegel; Elizabeth R Unger
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

2.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.

Authors:  S H Tan; L E Leong; P A Walker; H U Bernard
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

3.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

4.  The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions.

Authors:  B Daniel; A Rangarajan; G Mukherjee; E Vallikad; S Krishna
Journal:  J Gen Virol       Date:  1997-05       Impact factor: 3.891

5.  Methylation status of the long control region of HPV 16 in clinical cervical specimens.

Authors:  Die Hong; Feng Ye; Weiguo Lu; Ying Hu; Xiaoyun Wan; Yaxia Chen; Xing Xie
Journal:  Mol Med Rep       Date:  2008 Jul-Aug       Impact factor: 2.952

6.  The diagnostic value of the ThinPrep pap test in endometrial carcinoma: a prospective study with histological follow-up.

Authors:  Jianhong Zhou; Joseph F Tomashefski; Joram Sawady; Hector Ferrer; Amer Khiyami
Journal:  Diagn Cytopathol       Date:  2012-02-20       Impact factor: 1.582

7.  Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.

Authors:  Lisa Mirabello; Mark Schiffman; Arpita Ghosh; Ana C Rodriguez; Natasa Vasiljevic; Nicolas Wentzensen; Rolando Herrero; Allan Hildesheim; Sholom Wacholder; Dorota Scibior-Bentkowska; Robert D Burk; Attila T Lorincz
Journal:  Int J Cancer       Date:  2012-08-20       Impact factor: 7.396

8.  Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.

Authors:  Svetlana Vinokurova; Nicolas Wentzensen; Irene Kraus; Ruediger Klaes; Corina Driesch; Peter Melsheimer; Fjodor Kisseljov; Mattias Dürst; Achim Schneider; Magnus von Knebel Doeberitz
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

9.  Frequent p16 CpG island hypermethylation in primary remnant gastric cancer suggesting an independent carcinogenic pathway.

Authors:  Aya Mino; Naoyoshi Onoda; Masakazu Yashiro; Makoto Aya; Ichiro Fujiwara; Naoshi Kubo; Tetsuji Sawada; Masaichi Ohira; Yasuyuki Kato; Kosei Hirakawa
Journal:  Oncol Rep       Date:  2006-03       Impact factor: 3.906

10.  Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia.

Authors:  Mina Kalantari; Itzel E Calleja-Macias; Devansu Tewari; Bjørn Hagmar; Kathrine Lie; Hugo A Barrera-Saldana; Dorothy J Wiley; Hans-Ulrich Bernard
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more
  2 in total

1.  The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis.

Authors:  Sarah J Bowden; Ilkka Kalliala; Areti A Veroniki; Marc Arbyn; Anita Mitra; Kostas Lathouras; Lisa Mirabello; Marc Chadeau-Hyam; Evangelos Paraskevaidis; James M Flanagan; Maria Kyrgiou
Journal:  EBioMedicine       Date:  2019-11-12       Impact factor: 8.143

Review 2.  The role of HPV-induced epigenetic changes in cervical carcinogenesis (Review).

Authors:  Martha Laysla Ramos Da Silva; Beatriz Helena Dantas Rodrigues De Albuquerque; Thales Araújo De Medeiros Fernandes Allyrio; Valéria Duarte De Almeida; Ricardo Ney De Oliveira Cobucci; Fabiana Lima Bezerra; Vania Sousa Andrade; Daniel Carlos Ferreira Lanza; Jenner Christian Veríssimo De Azevedo; Josélio Maria Galvão De Araújo; José Veríssimo Fernandes
Journal:  Biomed Rep       Date:  2021-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.